311 related articles for article (PubMed ID: 26062758)
21. Newborn screening for all identifiable disorders with tandem mass spectrometry is cost effective: supporting arguments.
Therrell BL; Buechner C
Ann Acad Med Singap; 2008 Dec; 37(12 Suppl):32-4. PubMed ID: 19904443
[TBL] [Abstract][Full Text] [Related]
22. Selective screening for inborn errors of metabolism by tandem mass spectrometry in Egyptian children: a 5 year report.
Selim LA; Hassan SA; Salem F; Orabi A; Hassan FA; El-Mougy F; Mahmoud IG; El-Badawy A; Girgis MY; Elmonem MA; Mehaney D
Clin Biochem; 2014 Jun; 47(9):823-8. PubMed ID: 24731791
[TBL] [Abstract][Full Text] [Related]
23. Inborn errors of metabolism detectable by tandem mass spectrometry in Egypt: The first newborn screening pilot study.
Hassan FA; El-Mougy F; Sharaf SA; Mandour I; Morgan MF; Selim LA; Hassan SA; Salem F; Oraby A; Girgis MY; Mahmoud IG; El-Badawy A; El-Nekhely I; Moharam N; Mehaney DA; Elmonem MA
J Med Screen; 2016 Sep; 23(3):124-9. PubMed ID: 26790708
[TBL] [Abstract][Full Text] [Related]
24. Inborn Error of Metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS): An 8 year journey from pilot to current program.
Lim JS; Tan ES; John CM; Poh S; Yeo SJ; Ang JS; Adakalaisamy P; Rozalli RA; Hart C; Tan ET; Ranieri E; Rajadurai VS; Cleary MA; Goh DL
Mol Genet Metab; 2014; 113(1-2):53-61. PubMed ID: 25102806
[TBL] [Abstract][Full Text] [Related]
25. Health economic analysis of the neonatal screening program in Japan.
Hisashige A
Int J Technol Assess Health Care; 1994; 10(3):382-91. PubMed ID: 8071001
[TBL] [Abstract][Full Text] [Related]
26. Inborn errors of metabolism and expanded newborn screening: review and update.
Mak CM; Lee HC; Chan AY; Lam CW
Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058
[TBL] [Abstract][Full Text] [Related]
27. [Expanded newborn screening in the Region of Murcia, Spain. Three-years experience].
Juan-Fita MJ; Egea-Mellado JM; González-Gallego I; Moya-Quiles MR; Fernández-Sánchez A
Med Clin (Barc); 2012 Dec; 139(13):566-71. PubMed ID: 22137990
[TBL] [Abstract][Full Text] [Related]
28. Early diagnosis of inborn errors of metabolism. New technologies.
Radomyska B
Med Wieku Rozwoj; 2001; 5(1):95-103. PubMed ID: 11276508
[TBL] [Abstract][Full Text] [Related]
29. Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel.
Insinga RP; Laessig RH; Hoffman GL
J Pediatr; 2002 Oct; 141(4):524-31. PubMed ID: 12378192
[TBL] [Abstract][Full Text] [Related]
30. Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost-utility analysis.
Zhao Z; Chen C; Sun X; Zhou D; Huang X; Dong H
J Med Screen; 2022 Mar; 29(1):12-20. PubMed ID: 34102920
[TBL] [Abstract][Full Text] [Related]
31. Cost-benefit analysis of hyperphenylalaninemia due to 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency: for consideration of expanded newborn screening in Hong Kong.
Lee HH; Mak CM; Poon GW; Wong KY; Lam CW
J Med Screen; 2014 Jun; 21(2):61-70. PubMed ID: 24803483
[TBL] [Abstract][Full Text] [Related]
32. Newborn screening: experiences in the Middle East and North Africa.
Saadallah AA; Rashed MS
J Inherit Metab Dis; 2007 Aug; 30(4):482-9. PubMed ID: 17701444
[TBL] [Abstract][Full Text] [Related]
33. Cost-benefit analysis of G6PD screening in Lebanese newborn males.
Khneisser I; Adib SM; Loiselet J; Megarbane A
J Med Liban; 2007; 55(3):129-32. PubMed ID: 17966732
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France.
Hamers FF; Rumeau-Pichon C
BMC Pediatr; 2012 Jun; 12():60. PubMed ID: 22681855
[TBL] [Abstract][Full Text] [Related]
35. [Screening for neonatal inborn errors of metabolism by electrospray ionization-tandem mass spectrometry and follow-up].
Huang XW; Yang JB; Tong F; Yang RL; Mao HQ; Zhou XL; Huang XL; Yang LL; Huang CG; Zhao ZY
Zhonghua Er Ke Za Zhi; 2011 Oct; 49(10):765-70. PubMed ID: 22321184
[TBL] [Abstract][Full Text] [Related]
36. Biochemical testing for inborn errors of metabolism: experience from a large tertiary neonatal centre.
Dunne E; O'Reilly D; Murphy CA; Howard C; Kelleher G; Suttie T; Boyle MA; Brady JJ; Knerr I; Khuffash AE
Eur J Pediatr; 2022 Oct; 181(10):3725-3732. PubMed ID: 35945291
[TBL] [Abstract][Full Text] [Related]
37. Neonatal screening for inborn errors of metabolism.
Morris AA
Indian Pediatr; 2000 Dec; 37(12):1303-6. PubMed ID: 11119331
[No Abstract] [Full Text] [Related]
38. [25 years Austrian screening program for inborn errors of metabolism at the Vienna University].
Widhalm K
Wien Klin Wochenschr; 1992; 104(16):510-3. PubMed ID: 1413809
[TBL] [Abstract][Full Text] [Related]
39. [Neonatal screening by tandem mass spectrometry: an update].
Campos Hernández D
Rev Panam Salud Publica; 2010 Apr; 27(4):309-17. PubMed ID: 20512234
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience.
Karam PE; Habbal MZ; Mikati MA; Zaatari GE; Cortas NK; Daher RT
Clin Biochem; 2013 Dec; 46(18):1787-92. PubMed ID: 23994778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
